Join
Live feed
·
INSIDERFilingvia Quantisnow
Intellia Therapeutics Inc. logo

President and CEO Leonard John M sold $286,819 worth of shares (22,675 units at $12.65) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,147,064 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NTLA· Intellia Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTLA (Intellia Therapeutics Inc.) and more on Quantisnow.